The cancer death rate continues to decline in the U.S. but new cases are rising among women, potentially undermining p ...

Annual cancer statistics report identifies persistent racial and ethnic disparities and increases in certain cancers in women ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

A new study shows the number of people dying from cancer is on the decline, but more women and younger adults are being ...

Although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new ...

Though cancer mortality overall is dropping, the burden of disease is shifting to women and younger adults, American Cancer ...

Cancer deaths overall are falling, but the burden is shifting toward younger adults and women, the American Cancer Society ...

Today, the American Cancer Society (ACS) released Cancer Statistics, 2025, the organization's annual report on cancer facts ...

As KRAS-driven cancers continue to be among the most aggressive and elusive to treat, Silexion's progress with SIL-204 positions it as an important innovator to watch in the precision oncology space, ...

Silexion Therapeutics' SIL-204 exhibits synergy with key pancreatic cancer drugs in preclinical studies. Phase 2/3 trials ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and ...

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according ...